MimiX Biotherapeutics provides a point-of-care tissue engineering approach to regenerative, patient-tailored precision medicine
Innovative Solution
mimiX Biotherapeutics aims to deliver the next generation biofabrication technology, that will enable tissue manufacturing for therapeutic and diagnostic purposes. mimiX Biotherapeutics will make this vision a reality by providing an ultra-fast biomanufacturing technology capable of creating point-of-care patient-specific biological tissue equivalents for regenerative, personalized, and precision medicine.
Investment Funding
Last Funding Stage
Series A
Total Funding Amount
10.4K
Last Funding Date
16-10-2023
Startup Stage
Early Stage
Lead Investors
Venture Kick, Heraeus, Hermes Group, DM Capital, Asia Jetway
People
Founders
Marc Thurner
Tiziano Serra
About
mimiX Biotherapeutics aims to deliver the next generation biofabrication technology, that will enable tissue manufacturing for therapeutic and diagnostic purposes. mimiX Biotherapeutics will make this vision a reality by providing an ultra-fast biomanufacturing technology capable of creating point-of-care patient-specific biological tissue equivalents for regenerative, personalized, and precision medicine.
Something missing or incorrect on this page? Help us enrich this information
